Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 12, 2019 Filed Feb 14, 2019 19:27 UTC
Fenton AndrewExecutive Vice President
GrantPerformance Award Unit · Derivative 6,442.0896 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000064 · wf-form4_155019043148491.xml · derivative · entry 3

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,442.0896

Underlying: Common Stock · 6,442.0896 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:27 UTC
Fenton AndrewExecutive Vice President
GrantStock Option · Derivative 13,774 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000064 · wf-form4_155019043148491.xml · derivative · entry 2

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,251

Underlying: Common Stock · 13,774 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 12,853 options granted February 27, 2015 at an exercise price of $46.09 per option; 14,149 options granted February 19, 2016 at an exercise price of $41.83 per option; 3,872 options granted August 22, 2016 at an exercise price of $51.32 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 12,853 options granted February 27, 2015 at an exercise price of $46.09 per option; 14,149 options granted February 19, 2016 at an exercise price of $41.83 per option; 3,872 options granted August 22, 2016 at an exercise price of $51.32 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:27 UTC
Fenton AndrewExecutive Vice President
GrantRestricted Stock Unit · Derivative 3,428 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000064 · wf-form4_155019043148491.xml · derivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,275.7112

Underlying: Common Stock · 3,428 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,865.4580 RSUs will vest on February 19, 2019; 991.7401 RSUs will vest on August 22, 2019; 3,031.3841 RSUs will vest on December 6, 2019; 4,296.0854 RSUs will vest on February 14, 2020; 3,663.0436 RSUs will vest on February 13, 2021; and 3,428.0000 RSUs will vest on February 12, 2022.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:37 UTC
Trawicki RomanExecutive Vice President
GrantPerformance Award Unit · Derivative 8,137.376 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000069 · wf-form4_155019100811338.xml · derivative · entry 3

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,137.376

Underlying: Common Stock · 8,137.376 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:37 UTC
Trawicki RomanExecutive Vice President
GrantStock Option · Derivative 13,774 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000069 · wf-form4_155019100811338.xml · derivative · entry 2

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,106

Underlying: Common Stock · 13,774 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:37 UTC
Trawicki RomanExecutive Vice President
GrantRestricted Stock Unit · Derivative 3,428 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000069 · wf-form4_155019100811338.xml · derivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,269.7591

Underlying: Common Stock · 3,428 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 4,882.6301 RSUs will vest on February 19, 2019; 4,296.0854 RSUs will vest on February 14, 2020; 3,663.0436 RSUs will vest on February 13, 2021; and 3,428.0000 RSUs will vest on February 12, 2022.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:32 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantPerformance Award Unit · Derivative 16,274.7526 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000067 · wf-form4_155019076195107.xml · derivative · entry 3

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,274.7526

Underlying: Common Stock · 16,274.7526 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:32 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantStock Option · Derivative 20,661 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000067 · wf-form4_155019076195107.xml · derivative · entry 2

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,291

Underlying: Common Stock · 20,661 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 39,229 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 39,229 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:32 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantRestricted Stock Unit · Derivative 5,142 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000067 · wf-form4_155019076195107.xml · derivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,369.6572

Underlying: Common Stock · 5,142 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 9,765.2597 RSUs will vest on February 19, 2019; 8,593.1842 RSUs will vest on February 14, 2020; 6,869.2133 RSUs will vest on February 13, 2021; and 5,142.0000 RSUs will vest on February 12, 2022.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:31 UTC
Lagano RoxanneExecutive Vice President
GrantPerformance Award Unit · Derivative 8,815.4908 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000066 · wf-form4_155019066403826.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,815.4908

Underlying: Common Stock · 8,815.4908 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:31 UTC
Lagano RoxanneExecutive Vice President
GrantStock Option · Derivative 12,052 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000066 · wf-form4_155019066403826.xml · derivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,165

Underlying: Common Stock · 12,052 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 31,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 31,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:31 UTC
Lagano RoxanneExecutive Vice President
GrantRestricted Stock Unit · Derivative 2,999 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000066 · wf-form4_155019066403826.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,783.6708

Underlying: Common Stock · 2,999 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 5,289.0903 RSUs will vest on February 19, 2019; 4,603.0934 RSUs will vest on February 14, 2020; 3,892.4871 RSUs will vest on February 13, 2021; and 2,999.0000 RSUs will vest on February 12, 2022.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:29 UTC
Knupp Catherine A.Executive Vice President
GrantPerformance Award Unit · Derivative 14,918.523 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000065 · wf-form4_155019054771426.xml · derivative · entry 3

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,918.523

Underlying: Common Stock · 14,918.523 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:29 UTC
Knupp Catherine A.Executive Vice President
GrantStock Option · Derivative 20,661 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000065 · wf-form4_155019054771426.xml · derivative · entry 2

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,267

Underlying: Common Stock · 20,661 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,767 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,767 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:29 UTC
Knupp Catherine A.Executive Vice President
GrantRestricted Stock Unit · Derivative 5,142 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000065 · wf-form4_155019054771426.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,555.7157

Underlying: Common Stock · 5,142 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 8,951.3182 RSUs will vest on February 19, 2019; 8,593.1842 RSUs will vest on February 14, 2020; 6,869.2133 RSUs will vest on February 13, 2021; and 5,142.0000 RSUs will vest on February 12, 2022.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:23 UTC
Chen Heidi C.Executive Vice President
GrantPerformance Award Unit · Derivative 12,884.1794 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000062 · wf-form4_155019021163581.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,884.1794

Underlying: Common Stock · 12,884.1794 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:23 UTC
Chen Heidi C.Executive Vice President
GrantStock Option · Derivative 14,921 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000062 · wf-form4_155019021163581.xml · derivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,437

Underlying: Common Stock · 14,921 shares

Expires not disclosed

F6 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 22,850 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 22,850 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:23 UTC
Chen Heidi C.Executive Vice President
GrantRestricted Stock Unit · Derivative 3,713 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000062 · wf-form4_155019021163581.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,155.1859

Underlying: Common Stock · 3,713 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 7,730.9161 RSUs will vest on February 19, 2019; 6,445.1413 RSUs will vest on February 14, 2020; 5,266.1285 RSUs will vest on February 13, 2021; and 3,713.0000 RSUs will vest on February 12, 2022.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:22 UTC
Alaix Juan RamonDirector · Chief Executive Officer
GrantPerformance Award Unit · Derivative 85,442.4512 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 3

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,442.4512

Underlying: Common Stock · 85,442.4512 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:22 UTC
Alaix Juan RamonDirector · Chief Executive Officer
GrantStock Option · Derivative 110,192 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 2

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,073,155

Underlying: Common Stock · 110,192 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51.

Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:22 UTC
Alaix Juan RamonDirector · Chief Executive Officer
GrantRestricted Stock Unit · Derivative 27,425 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,604.5574

Underlying: Common Stock · 27,425 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 51,270.1685 RSUs will vest on February 19, 2019; 44,811.0081 RSUs will vest on February 14, 2020; 37,098.3808 RSUs will vest on February 13, 2021; and 27,425.0000 RSUs will vest on February 12, 2022.

Read SEC document
January 14, 2019 Filed Jan 16, 2019 21:20 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionStock Option · Derivative 3,567 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000020 · wf-form4_154767363241763.xml · derivative · entry 3

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,630

Underlying: Common Stock · 3,567 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 3,567 options granted January 31, 2013 at an exercise price of $26.00 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 39,229 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
January 14, 2019 Filed Jan 16, 2019 21:20 UTC
Lewis Clinton A. Jr.Executive Vice President
SaleCommon Stock 6,125 $85.21 $521,911.25
Disclosure

SEC source: 0001555280-19-000020 · wf-form4_154767363241763.xml · nonDerivative · entry 2

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,945

F1 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
January 14, 2019 Filed Jan 16, 2019 21:20 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionCommon Stock 3,567 $26.00 $92,742.00
Disclosure

SEC source: 0001555280-19-000020 · wf-form4_154767363241763.xml · nonDerivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 21:59 UTC
PECK KRISTIN CExecutive Vice President
GrantPhantom Stock Unit · Derivative 333.4517 $27.25 $9,086.56
Disclosure

SEC source: 0001555280-19-000017 · wf-form4_154758955571458.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,090.5834

Underlying: Common Stock · 105.584 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 16:28 UTC
Fenton AndrewExecutive Vice President
GrantPhantom Stock Unit · Derivative 299.7523 $27.25 $8,168.25
Disclosure

SEC source: 0001555280-19-000011 · wf-form4_154758767287568.xml · derivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,396.5934

Underlying: Common Stock · 94.9134 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 22:04 UTC
David GlennChief Financial Officer
GrantPhantom Stock Unit · Derivative 309.3692 $27.25 $8,430.31
Disclosure

SEC source: 0001555280-19-000018 · wf-form4_154758982452695.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,599.9097

Underlying: Common Stock · 97.9585 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 21:55 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 244.5299 $27.25 $6,663.44
Disclosure

SEC source: 0001555280-19-000016 · wf-form4_154758932880066.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,574.0446

Underlying: Common Stock · 77.4278 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 21:51 UTC
Alaix Juan RamonDirector · Chief Executive Officer
GrantPhantom Stock Unit · Derivative 592.8011 $27.25 $16,153.83
Disclosure

SEC source: 0001555280-19-000015 · wf-form4_154758905622095.xml · derivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,153.7358

Underlying: Common Stock · 187.7043 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 21:46 UTC
Knupp Catherine A.Executive Vice President
GrantPhantom Stock Unit · Derivative 309.3692 $27.25 $8,430.31
Disclosure

SEC source: 0001555280-19-000014 · wf-form4_154758878965248.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,888.4427

Underlying: Common Stock · 97.9585 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 21:39 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantPhantom Stock Unit · Derivative 333.4517 $27.25 $9,086.56
Disclosure

SEC source: 0001555280-19-000013 · wf-form4_154758834683881.xml · derivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,465.7652

Underlying: Common Stock · 105.584 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 11, 2019 Filed Jan 15, 2019 21:32 UTC
Chen Heidi C.Executive Vice President
GrantPhantom Stock Unit · Derivative 268.6125 $27.25 $7,319.69
Disclosure

SEC source: 0001555280-19-000012 · wf-form4_154758796086806.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268.6125

Underlying: Common Stock · 85.0533 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:19 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000002 · wf-form4_154646395153651.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,113

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 2,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 31,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:19 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 2,000 $85.30 $170,600.00
Disclosure

SEC source: 0001555280-19-000002 · wf-form4_154646395153651.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,023

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:19 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 2,000 $30.89 $61,780.00
Disclosure

SEC source: 0001555280-19-000002 · wf-form4_154646395153651.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.

Read SEC document
December 17, 2018 Filed Dec 18, 2018 16:15 UTC GrantPhantom Stock Unit · Derivative 294.3254 $84.94 $25,000.00
Disclosure

SEC source: 0001555280-18-000282 · wf-form4_154516772586545.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600.9867

Underlying: Common Stock · 294.3254 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 17, 2018 Filed Dec 18, 2018 21:18 UTC GrantPhantom Stock Unit · Derivative 294.3254 $84.94 $25,000.00
Disclosure

SEC source: 0001555280-18-000283 · wf-form4_154516790513256.xml · derivative · entry 1

PARENT LOUISE M · CIK 0001209456 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,825.6578

Underlying: Common Stock · 294.3254 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 22:20 UTC
Chen Heidi C.Executive Vice President
OtherPhantom Stock Unit · Derivative 15,760.9865 $29.50 $464,949.10
Disclosure

SEC source: 0001555280-18-000277 · wf-form4_154413480498177.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,968.9976 shares

Expires not disclosed

F3 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F4 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F3 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F3 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 22:20 UTC
Chen Heidi C.Executive Vice President
OtherCommon Stock 2,534.468 $93.57 $237,150.17
Disclosure

SEC source: 0001555280-18-000277 · wf-form4_154413480498177.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 0

F2 · security: Represents common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan.

F2 · balance_after: Represents common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 22:20 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 2,500 $93.51 $233,775.00
Disclosure

SEC source: 0001555280-18-000277 · wf-form4_154413480498177.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,662

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.51 to $93.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 16:17 UTC SaleCommon Stock 3,205 $93.74 $300,436.70
Disclosure

SEC source: 0001555280-18-000275 · wf-form4_154387184520751.xml · nonDerivative · entry 1

Reed Willie M · CIK 0001601695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 566

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.73 to $93.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 21:16 UTC
PECK KRISTIN CExecutive Vice President
Exercise / conversionStock Option · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000273 · wf-form4_154214377349800.xml · derivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,658

Underlying: Common Stock · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 7,500 options granted January 31, 2013 at an exercise price of $26.00 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 40,385 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 21:16 UTC
PECK KRISTIN CExecutive Vice President
SaleCommon Stock 11,500 $94.78 $1,089,970.00
Disclosure

SEC source: 0001555280-18-000273 · wf-form4_154214377349800.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,652

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.24 to $95.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 21:16 UTC
PECK KRISTIN CExecutive Vice President
Exercise / conversionCommon Stock 7,500 $26.00 $195,000.00
Disclosure

SEC source: 0001555280-18-000273 · wf-form4_154214377349800.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 08, 2018 Filed Nov 9, 2018 21:22 UTC
Alaix Juan RamonDirector · Chief Executive Officer
Exercise / conversionStock Option · Derivative 150,306 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · derivative · entry 3

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 962,963

Underlying: Common Stock · 150,306 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 150,306 options granted January 31, 2013 at an exercise price of $26.00 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; and 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
November 08, 2018 Filed Nov 9, 2018 21:22 UTC
Alaix Juan RamonDirector · Chief Executive Officer
SaleCommon Stock 150,306 $94.96 $14,273,057.76
Disclosure

SEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · nonDerivative · entry 2

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,013

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.54 to $95.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 08, 2018 Filed Nov 9, 2018 21:22 UTC
Alaix Juan RamonDirector · Chief Executive Officer
Exercise / conversionCommon Stock 150,306 $26.00 $3,907,956.00
Disclosure

SEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · nonDerivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 12, 2018 Filed Oct 16, 2018 20:56 UTC
PECK KRISTIN CExecutive Vice President
GrantPhantom Stock Unit · Derivative 277.6642 $28.05 $7,788.48
Disclosure

SEC source: 0001555280-18-000264 · wf-form4_153972340221515.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,757.1317

Underlying: Common Stock · 87.6094 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
October 12, 2018 Filed Oct 16, 2018 16:52 UTC
Fenton AndrewExecutive Vice President
GrantPhantom Stock Unit · Derivative 204.6481 $28.05 $5,740.38
Disclosure

SEC source: 0001555280-18-000262 · wf-form4_153972313113686.xml · derivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,096.8411

Underlying: Common Stock · 64.5712 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
October 12, 2018 Filed Oct 16, 2018 20:54 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 203.6193 $28.05 $5,711.52
Disclosure

SEC source: 0001555280-18-000263 · wf-form4_153972326500676.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,329.5147

Underlying: Common Stock · 64.2466 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.